Professor Goldsteins research contributions include: Co-discovery and isolation of the thymosin family of peptides in the 1960s First clinical trials of thymosin preparations in immunodeficient children (1974) Characterization of thymosin beta-4s actin-binding and wound healing properties Development of therapeutic applications for tissue repair and regeneration Over 450 published scientific articles and 25+ patents related to thymosins Leadership in translating thymosin research toward clinical development Disclaimer: This spotlight is provided for educational purposes to acknowledge scientific contributions to BPC-157 and TB-500/thymosin beta-4 research
Consultation & Labs We discuss your symptoms, goals, and medical history
2017 Cell study, with subsequent independent confirmations in human chondrocytes (Huang 2021), mouse Leydig cells (Zhang 2020
In response to injury, renal tubular epithelial cells undergo morphological changes and secrete bioactive molecules, driving interstitial inflammation and fibrosis, ultimately leading to the development of chronic kidney disease (CKD) and end-stage renal disease (ESRD) (13, 14)
It is well-known that vitamin C supports immune function
